이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - peginterferon alfa 2a 180 mcg / 0.5 ml - solution for injection - peginterferon alfa-2a - chronic hepatitis b: pegasys is indicated for the treatment of both hbeag- positive and hbeag -negative chronic hepatitis b in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation.chronic hepatitis c: pegasys is indicated for the treatment of chronic hepatitis c in adult patients who are positive for serum hcv-rna including patients with compensated cirrhosis and/or co-infected with clinically stable hiv. the optimal way to use pegasys in patients with chronic hepatitis c is in combination with ribavirin. the combination of pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated ) alone or in combination therapy with ribavirin. monotherapy is indicated mainly in case of intolerance or contraindication to ribavirin.

이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - mycophenolate mofetil - קפסולות - mycophenolate mofetil 250 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. cellcept should be used concomitantly with cyclosporin and corticosteroids.allogenic hepatic transplant.

이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - mycophenolate mofetil - טבליות מצופות פילם - mycophenolate mofetil 500 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. cellcept should be used concomitantly with cyclosporin and corticosteroids.allogenic hepatic transplant.

이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - tocilizumab - תרכיז להכנת תמיסה לאינפוזיה - tocilizumab 20 mg/ml - tocilizumab - tocilizumab - actemra (tocilizumab) is indicated for reducing signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response to one or more dmards (disease modifying antirhematic drugs) or tnf antagonists or in whom dmards cannot be used. actemra can be used alone or in combination with methotrexate or other dmards.actemra® has been shown to reduce progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. actemra® is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 2 years of age and older.

이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - mefloquine as hydrochloride 250 mg - tablets - mefloquine - for the treatment and prophylaxis of plasmodium falciparum malaria which is resistant to other antimalarials.

이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - flumazenil 0.1 mg/ml - solution for injection - flumazenil - benzodiazepine antagonist for reversal of benzodiazepine anasthesia, as well as for patients with benzodiazepine intoxication.

이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - vismodegib - קפסולות - vismodegib 150 mg - erivedge® is indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation

이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - ocrelizumab - תרכיז להכנת תמיסה לאינפוזיה - ocrelizumab 30 mg/ml - ocrelizumab

이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - alectinib as hydrochloride - קפסולות - alectinib as hydrochloride 150 mg

이스라엘 - 히브리어 - Ministry of Health

roche pharmaceuticals (israel) ltd - obinutuzumab - תרכיז להכנת תמיסה לאינפוזיה - obinutuzumab 1000 mg / 40 ml - obinutuzumab